Laddar...
Development of tumor lysis syndrome (TLS): A potential risk factor in cancer patients receiving anticancer therapy
Tumor lysis syndrome (TLS) is characterized by hyperuricaemia, hyperphosphatemia, hyperkalaemia, as well as hypocalcaemia due to the breakdown of tumor cells undergoing cancer therapy (chemo/radio). Therefore it is of interest to evaluate oxidative stress using selective biological markers [Malondia...
Sparad:
| I publikationen: | Bioinformation |
|---|---|
| Huvudupphovsmän: | , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Biomedical Informatics
2014
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4261116/ https://ncbi.nlm.nih.gov/pubmed/25512688 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6026/97320630010703 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|